Table 4 Risk of mortality as a function of multivariable patient comorbidities and characteristics
Adjusted Hazard Ratio | 95% Confidence Interval | p | ||
|---|---|---|---|---|
Lower | Upper | |||
HAART (Yes vs No) | 0.997 | 0.639 | 1.555 | .99 |
Age (per 5 year increase) | 1.050 | 0.939 | 1.173 | .39 |
Male vs Female | 1.394 | 0.890 | 2.185 | .15 |
Neurological symptoms (Yes vs No) | 2.138 | 1.267 | 3.608 | .004 |
Clinical Stage (vs Stage 0–2) | .27 | |||
Stage 3 | 3.261 | 0.777 | 13.686 | .11 |
Stage 4 | 2.895 | 0.671 | 12.489 | .15 |
ICSOL (Yes vs No) | 0.966 | 0.503 | 1.854 | .92 |
Pneumonia (Yes vs No) | 1.435 | 0.817 | 2.519 | .21 |